Rhythm BiosciencesFRA:0RY +10.58%31 Days Inventory is 80.57 as of Dec. 2025, which is 33% below its 10-year median of 120.04. GuruFocus rates FRA:0RY with a GF Score™ of 31/100. The stock has 5 warning signs investors should review. Among 177 Medical Diagnostics & Research companies, Rhythm Biosciences ranks worse than 81.92% on this metric.
The historical rank and industry rank for Rhythm Biosciences's Days Inventory or its related term are showing as below:
FRA:0RY'
s Days Inventory Range Over the Past 10 Years
Min: 120.04 Med: 120.04 Max: 172.55
Current: 172.55
During the past 8 years, Rhythm Biosciences's highest Days Inventory was 172.55. The lowest was 120.04. And the median was 120.04.
FRA:0RY's Days Inventory is ranked worse than 81.92% of 177
companies
in the Medical Diagnostics & Research industry
Industry Median: 70.8
vs FRA:0RY: 172.55
Rhythm Biosciences's Days Inventory
increased
from Dec. 2024 (0.00) to Dec. 2025 (80.57).
It might indicate that Rhythm Biosciences's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Rhythm Biosciences's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rhythm Biosciences's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 1.60.
Rhythm Biosciences (FRA:0RY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Rhythm Biosciences's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Rhythm Biosciences's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Rhythm Biosciences Days Inventory Related Terms
Rhythm Biosciences Days Inventory Historical Data
* Premium members only.
The historical data trend for Rhythm Biosciences's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0RY vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Rhythm Biosciences's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rhythm Biosciences Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's Days Inventory distribution charts can be found below:
* The bar in red indicates where Rhythm Biosciences's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rhythm Biosciences (FRA:0RY) has a Days Inventory of 80.57 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Rhythm Biosciences and its competitors. This is 33% below median its historical median of 120.04. Over the past decade, Rhythm Biosciences' Days Inventory has ranged from 120.04 to 172.55. According to the industry distribution chart, Rhythm Biosciences ranks #145 out of 177 companies in the Medical Diagnostics & Research industry, placing it in the top 81.9%.
Is Rhythm Biosciences' Days Inventory too high?
Rhythm Biosciences' current Days Inventory of 80.57 is 33% below median its 10-year median of 120.04. Over the past 10 years, this metric has ranged from a low of 120.04 to a high of 172.55. The Medical Diagnostics & Research industry median Days Inventory is 70.80. Rhythm Biosciences' value of 80.57 is 13.8% above this industry median. Based on the distribution chart, Rhythm Biosciences ranks #145 out of 177 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Rhythm Biosciences has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Rhythm Biosciences' Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Rhythm Biosciences ranks #145 out of 177 companies for Days Inventory. This places Rhythm Biosciences in the lower half of its industry. The industry median Days Inventory is 70.80. Rhythm Biosciences' value of 80.57 is 13.8% above this benchmark. Historically, Rhythm Biosciences' own Days Inventory has ranged from 120.04 to 172.55 over the past decade. While the company's 10-year median is 120.04 vs. the industry median of 70.80, Rhythm Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 70.80, based on 177 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rhythm Biosciences's current Days Inventory of 80.57 is 13.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Rhythm Biosciences and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 70.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rhythm Biosciences's current Days Inventory is 80.57, which is 33% below median its own 10-year median of 120.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rhythm Biosciences stock overvalued right now?
Rhythm Biosciences (FRA:0RY) has a current Days Inventory of 80.57. The current Days Inventory is 80.57, which is 33% below median its 10-year median of 120.04 and 13.8% above the Medical Diagnostics & Research industry median of 70.80. Rhythm Biosciences' overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Rhythm Biosciences (FRA:0RY), the current Days Inventory is 80.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. The product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. The company operates predominantly in one business and geographical segment which is the research and development of biosciences in Australia.
31GF Score
Get the complete analysis for FRA:0RY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0RY has been successfully added to your 
